BXP.L

Beximco Pharmaceuticals Limited [BXP.L] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

BXP.L Stock Summary

Top 10 Correlated ETFs

BXP.L


Top 10 Correlated Stocks

BXP.L


In the News

BXP.L Financial details

Company Rating
Buy
Market Cap
185.14M
Income
4.61B
Revenue
39.27B
Book val./share
-
Cash/share
-
Dividend
0.03
Dividend %
0.08%
Employees
5.5K
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
5.53
Forward P/E
-
PEG
-1.9
P/S
0.65
P/B
0.58
P/C
-
P/FCF
9.46
Quick Ratio
0.09
Current Ratio
1.57
Debt / Equity
0.24
LT Debt / Equity
0.05
-
-
EPS (TTM)
8.14
EPS next Y
-
EPS next Q
-
EPS this Y
-9.93%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
8.74%
Revenue last 5Y
11.47%
Revenue Q/Q
5.02%
EPS Q/Q
-
-
-
-
-
SMA20
5.13%
SMA50
5.13%
SMA100
10.81%
Inst Own
-
Inst Trans
-
ROA
7%
ROE
11%
ROC
0.13%
Gross Margin
44%
Oper. Margin
18%
Profit Margin
12%
Payout
34%
Shs Outstand
1.13B
Shs Float
297.32M
-
-
-
-
Target Price
-
52W Range
33.3-60.0
52W High
-30.83%
52W Low
+25.76%
RSI
61
Rel Volume
64.41
Avg Volume
59.77K
Volume
3.85M
Perf Week
2.47%
Perf Month
7.79%
Perf Quarter
16.9%
Perf Half Y
9.21%
-
-
-
-
Beta
0.65
-
-
Volatility
0.36%, 1.26%
Prev Close
0%
Price
41.5
Change
-

BXP.L Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-06-30

Metric History 2019-06-302020-06-302021-06-302022-06-30 2023-06-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
51.1557.4466.1177.7188
Net income per share
6.87.8811.4911.4810.34
Operating cash flow per share
6.6312.43012.3113.64
Free cash flow per share
-3.557.33-5.735.727.56
Cash per share
2.091.421.512.622.55
Book value per share
66.3272.8783.0191.0197.89
Tangible book value per share
62.7369.4679.4488.3294.62
Share holders equity per share
66.3272.8783.0191.0197.89
Interest debt per share
32.5425.8319.0329.9826.66
Market cap
16.23B14.88B44.06B34.79B21.35B
Enterprise value
29.1B24.75B51.02B45.99B30.83B
P/E ratio
5.354.238.596.794.63
Price to sales ratio
0.710.581.4910.54
POCF ratio
5.482.6806.333.51
PFCF ratio
-10.244.55-17.2213.626.33
P/B Ratio
0.550.461.190.860.49
PTB ratio
0.550.461.190.860.49
EV to sales
1.280.971.731.330.79
Enterprise value over EBITDA
5.854.377.055.984.19
EV to operating cash flow
9.834.4608.375.07
EV to free cash flow
-18.367.57-19.9418.019.14
Earnings yield
0.190.240.120.150.22
Free cash flow yield
-0.10.22-0.060.070.16
Debt to equity
0.460.320.210.30.24
Debt to assets
0.270.210.150.190.15
Net debt to EBITDA
2.591.740.961.461.29
Current ratio
1.041.151.471.451.57
Interest coverage
4.925.537.756.895.61
Income quality
0001.070
Dividend Yield
0.030.040.010.050.07
Payout ratio
0.170.170.110.320.34
Sales general and administrative to revenue
0.030.030.030.030.03
Research and developement to revenue
00.010.010.010
Intangibles to total assets
0.040.040.040.080.08
Capex to operating cash flow
-1.54-0.410-0.54-0.45
Capex to revenue
-0.2-0.09-0.09-0.08-0.07
Capex to depreciation
000-7.940
Stock based compensation to revenue
00000
Graham number
100.73113.68146.52153.35150.91
ROIC
0.090.10.120.10.1
Return on tangible assets
0.060.070.10.080.07
Graham Net
-33.83-29.88-15.53-51.84-31.21
Working capital
518.33M1.69B4.42B5.68B7.61B
Tangible asset value
27.98B30.98B35.44B39.4B42.22B
Net current asset value
-6.09B-4.27B-1.11B-3.09B-661.26M
Invested capital
0.460.320.210.30.24
Average receivables
002.25B-3.31B-5.56B
Average payables
1.04B1.28B1.71B2.22B3B
Average inventory
6.19B6.69B7.26B9.46B12.04B
Days sales outstanding
0055.71-117.120
Days payables outstanding
32.6738.9446.0747.7258.72
Days of inventory on hand
199.02178.88182.96215.34215.36
Receivables turnover
006.55-3.120
Payables turnover
11.179.377.927.656.22
Inventory turnover
1.832.041.991.691.69
ROE
0.10.110.140.130.11
Capex per share
-10.19-5.1-5.73-6.59-6.07

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q4

Metric History 2022-06-302022-09-302022-12-312023-03-31 2023-06-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
19.5921.9422.1721.420
Net income per share
1.893.242.772.130
Operating cash flow per share
2.183.242.772.130
Free cash flow per share
-0.291.711.221.010
Cash per share
2.621.962.792.210
Book value per share
91.0194.2593.5295.650
Tangible book value per share
88.3291.7391.0393.050
Share holders equity per share
91.0194.2593.5295.650
Interest debt per share
28.3827.6226.5326.250
Market cap
34.79B34.39B30.42B22.08B0
Enterprise value
45.99B45.53B40.67B32.48B9.48B
P/E ratio
10.325.946.155.810
Price to sales ratio
3.983.513.082.310
POCF ratio
35.7623.7624.5923.220
PFCF ratio
-269.3944.975649.110
P/B Ratio
0.860.820.730.520
PTB ratio
0.860.820.730.520
EV to sales
5.264.654.113.40.94
Enterprise value over EBITDA
35.5220.7620.4520.995.83
EV to operating cash flow
47.2731.4632.8834.175.34
EV to free cash flow
-356.1459.5474.8872.2710.07
Earnings yield
0.020.040.040.040
Free cash flow yield
00.020.020.020
Debt to equity
0.30.290.280.270.24
Debt to assets
0.190.180.170.170.15
Net debt to EBITDA
8.655.085.166.725.83
Current ratio
1.451.591.471.581.57
Interest coverage
4.056.795.924.775
Income quality
1.151110
Dividend Yield
0000.070
Payout ratio
0.01001.630.01
Sales general and administrative to revenue
0.110.030.030.040.02
Research and developement to revenue
0.010000
Intangibles to total assets
0.080.080.070.070.08
Capex to operating cash flow
-1.13-0.47-0.56-0.53-0.47
Capex to revenue
-0.13-0.07-0.07-0.05-0.08
Capex to depreciation
-8.460000
Stock based compensation to revenue
00000
Graham number
62.1982.9476.3967.720
ROIC
0.020.030.030.020.02
Return on tangible assets
0.010.020.020.010.02
Graham Net
-28.15-26.64-29.47-32.640
Working capital
5.68B7.32B6.85B7.62B7.61B
Tangible asset value
39.4B40.92B40.61B41.51B42.22B
Net current asset value
-3.09B-1.8B-2.32B-1.36B-661.26M
Invested capital
0.30.290.280.270.24
Average receivables
3.55B3.11B3.27B1.65B0
Average payables
2.69B2.5B2.91B3.38B3.5B
Average inventory
10.87B11.8B12.96B13.39B13.15B
Days sales outstanding
30.5129.8630.0200
Days payables outstanding
43.1142.6454.258.4654.8
Days of inventory on hand
194.56209.31221.95224.91201
Receivables turnover
2.953.01300
Payables turnover
2.092.111.661.541.64
Inventory turnover
0.460.430.410.40.45
ROE
0.020.030.030.020.02
Capex per share
-2.47-1.53-1.56-1.120

BXP.L Frequently Asked Questions

What is Beximco Pharmaceuticals Limited stock symbol ?

Beximco Pharmaceuticals Limited is a BD stock and trading under the symbol BXP.L

What is Beximco Pharmaceuticals Limited stock quote today ?

Beximco Pharmaceuticals Limited stock price is $41.5 today.

Is Beximco Pharmaceuticals Limited stock public?

Yes, Beximco Pharmaceuticals Limited is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap